Literature DB >> 3789618

Duodenal ulcer perforation: the effect of H2 antagonists?

P Gillen, W Ryan, A L Peel, H B Devlin.   

Abstract

One hundred and two patients with perforated duodenal ulcers over a 13 year period (1970 to 1982) have been prospectively followed-up at a special gastric clinic. Of the 37 patients with perforation of their acute ulcer, 34 were treated by oversew and three had an initial definitive operation (vagotomy and drainage). The remaining 65 patients presented with perforation of a chronic ulcer and 54 were treated by oversew and 11 underwent definitive surgery--nine had vagotomy and drainage and two had partial gastrectomies. Seven of the 34 patients (20.5%) with acute ulcer perforation treated by simple oversew subsequently required definitive ulcer surgery at a mean 17.5 months after perforation and 31 of the 54 patients (57.4%) with chronic ulcer perforations required definitive surgery at a mean 27.4 months after perforation. The introduction of H2 antagonists in 1977 did not alter the re-operation rate in patients with chronic ulcer perforation managed by oversew. Results of this study provide further evidence in favour of treating patients with perforation of their chronic duodenal ulcer by definitive surgery whenever possible.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3789618      PMCID: PMC2498339     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  14 in total

1.  Progress after Perforated Peptic Ulcer.

Authors:  C F Illingworth; L D Scott; R A Jamieson
Journal:  Br Med J       Date:  1946-05-25

2.  Perforated duodenal ulcer: long-term follow-up.

Authors:  G J Nemanich; D M Nicoloff
Journal:  Surgery       Date:  1970-05       Impact factor: 3.982

3.  Factors influencing the treatment of perforated duodenal ulcer.

Authors:  J B Mark
Journal:  Surg Gynecol Obstet       Date:  1969-08

4.  Surgical operation rates: a twelve year experience in Stockton on Tees.

Authors:  D S Quill; H B Devlin; J A Plant; K R Denham; R A McNay; D Morris
Journal:  Ann R Coll Surg Engl       Date:  1983-07       Impact factor: 1.891

5.  Course of patients with perforated duodenal ulcers.

Authors:  G A Hofkin
Journal:  Am J Surg       Date:  1966-02       Impact factor: 2.565

6.  Non-steroidal anti-inflammatory drugs and peptic ulcer perforation.

Authors:  D S Collier; J A Pain
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

7.  Immediate definitive surgery for perforated duodenal ulcers: a prospective controlled trial.

Authors:  J Boey; N W Lee; J Koo; P H Lam; J Wong; G B Ong
Journal:  Ann Surg       Date:  1982-09       Impact factor: 12.969

8.  Cimetidine and perforated peptic ulcer.

Authors:  A J McKay; C S McArdle
Journal:  Br J Surg       Date:  1982-06       Impact factor: 6.939

9.  The ulcer diathesis in perforated duodenal ulcer disease. Experience with 252 patients during a twenty-five year period.

Authors:  F Jarrett; G A Donaldson
Journal:  Am J Surg       Date:  1972-04       Impact factor: 2.565

10.  A prospective study of operative risk factors in perforated duodenal ulcers.

Authors:  J Boey; J Wong; G B Ong
Journal:  Ann Surg       Date:  1982-03       Impact factor: 12.969

View more
  2 in total

1.  Generalized peritonitis in India--the tropical spectrum.

Authors:  L Sharma; S Gupta; A S Soin; S Sikora; V Kapoor
Journal:  Jpn J Surg       Date:  1991-05

2.  Surgeons' attitudes to the operative management of duodenal ulcer perforation and haemorrhage.

Authors:  M D Stringer; A E Cameron
Journal:  Ann R Coll Surg Engl       Date:  1988-07       Impact factor: 1.891

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.